Pharmacotherapy for Management of Type 2 Diabetes and CKM Syndrome: SGLT2 Inhibitors and GLP-1-Based Therapies for All vs a Risk-Based Approach?

Authors

Ambarish Pandey, Kershaw V Patel

Published in

Journal of the American College of Cardiology. Volume 88. Issue 5. Pages 559-562. Aug 04, 2026.

PMID:
42554383
Bibliographic data and abstract were imported from PubMed on 05 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.